RhumbLine Advisers’s Telomir Pharmaceuticals TELO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,732
| Closed | -$37.9K | – | 4285 |
|
|
2025
Q1 | $37.9K | Buy |
11,732
+3,132
| +36% | +$10.1K | ﹤0.01% | 3631 |
|
|
2024
Q4 | $35.4K | Buy |
8,600
+4,424
| +106% | +$18.2K | ﹤0.01% | 3723 |
|
|
2024
Q3 | $26.8K | Sell |
4,176
-886
| -18% | -$5.69K | ﹤0.01% | 3781 |
|
|
2024
Q2 | $24.3K | Buy |
+5,062
| New | +$24.3K | ﹤0.01% | 3836 |
|